22 Apr 2021 --- There is a noticeable rise in nutraceutical companies seeking to enter the pharmaceutical industry. Broader networking and sales opportunities are financially attractive, but sharper regulatory hurdles make it difficult for “just anyone” to make the transition. Reflecting on their respective initial experiences of these industry overlaps, experts from Pharmactive Biotech and Aker Biomarine reveal to NutritionInsight the challenges faced and opportunities yet unseized.
